Weight-Loss Drugs Change How People Drink in British Pubs

In recent years, a new type of medicine has changed the lives of millions of people. These drugs, known as GLP-1 medications, are designed to help people lose weight. According to The Guardian Health, the use of these drugs has grown very quickly, with 10 million people in the United States using them last year. While these medicines are helping people reach their health goals, they are also starting to change how people spend their money and time in social settings like pubs and bars.

Heineken, one of the world’s largest beer companies, recently shared a presentation with British pubs and bars to talk about these changes. The company warned that the growing use of GLP-1 drugs could lead to a drop in the sales of beer and cider. The main reason for this change is that these drugs often make people feel full, which reduces their desire to drink alcohol. As a result, the traditional habit of sitting in a pub for several hours and drinking multiple pints of beer may become less common.

According to The Guardian Health, Heineken suggests that pubs should change how they do business to keep customers coming back. The company recommended that bars promote smaller portions, such as half-pints, and offer more drinks that have little or no alcohol. They also suggested pairing drinks with small plates of food. A spokesperson for Heineken explained that they are watching these trends closely as they look toward 2027. The company noted that while some people are drinking less, others are simply becoming more careful about what they choose to drink, often picking higher-quality products or healthier options.

Not everyone in the drink industry feels the same way about these changes. While some research companies, including Circana, NIQ, and KAM, have found evidence that people using these drugs are drinking less, other big companies have a different view. For example, the company that makes Guinness, Diageo, told its investors that it believes any impact from these weight-loss drugs will be small and easy to manage. Meanwhile, the brewer Carlsberg stated that current data does not support the idea that weight-loss drugs are significantly changing beer consumption trends.

This situation highlights a larger shift in how people think about their health and wellbeing. Heineken noted that the changes they see in GLP-1 users are not just about the medication itself. Instead, these habits are part of a wider trend where consumers are choosing to be more careful and intentional with their health. People are increasingly interested in moderation—the act of not having too much of something—and are looking for more variety in what they consume.

For the British hospitality industry, which relies heavily on beer sales, these trends are important to understand. According to The Guardian Health, the total sales of beer in British pubs, bars, and restaurants reached almost £14 billion in the year leading up to February. However, only a small part of that money came from low-alcohol or zero-alcohol products. As more people use weight-loss drugs, pubs may need to adapt their menus and marketing strategies to match the changing habits of their customers. Whether this will lead to a permanent change in pub culture or just a small shift in what people order remains to be seen as the market continues to evolve.